Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18-55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial
利用第二代分子钳技术稳定融合前构象的严重急性呼吸综合征冠状病毒2刺突蛋白亚单位疫苗在18-55岁成年人中的安全性和免疫原性：一项随机、双盲、活性对照的I期试验
期刊:Journal of Infectious Diseases
影响因子:4.5
doi:10.1093/infdis/jiaf568
Chappell, Keith J; Mordant, Francesca L; Amarilla, Alberto A; Modhiran, Naphak; Liang, Benjamin; Li, Zheyi; Lackenby, Julia A; Jaberolansar, Noushin; O'Donnell, Jake; Kienzle, Vivian; Kommajosyula, Varsha; Tardiota, Nicolas; Bennet, Jillian K; Henderson, Christina L; Dalrymple, Rhiannon L; Goh, Justin; Hoger, Kym; Gillard, Marianne; Jones, Martina L; Hughes, Karen; Hughes, Ben; Barnes, James; Reading, Patrick C; Ranasinghe, Charani; Subbarao, Kanta; Munro, Trent P; Young, Paul R; Watterson, Daniel
